This case envisions circumstances in which a pharmaceutical organization, in preparation its annual shareholders' meeting, converses the likelihood of activist dislocation.
PUBLICATION DATE: November 15, 2012 PRODUCT #: BH495-HCB-ENG
This is just an excerpt. This case is about INNOVATION & ENTREPRENEURSHIP